← All public profiles

Raw 3D-CAM severity score — Raw 3D-CAM Delirium Severity Score

2020

An alternative 0-20 severity score formed by summing positive findings already collected during the 20 core 3D-CAM results. It is a severity version rather than a separate diagnostic instrument.

Severity measurementMonitoring / repeated screeningDetailed research assessmentNo eligible DTA study identifiedVersion or adaptation

Version or adaptation

This page describes a version or adaptation within a related instrument family. This profile remains public for clinical and bibliographic context, but it does not add to the headline count of independent core families.

What this tool is and how to interpret its evidence

Raw 3D-CAM is an alternative method for grading delirium severity from an assessment already completed with the parent 3D-CAM. It adds the positive findings across the 20 core interview and observer-rated results, producing a total from 0 to 20. The contributing results comprise cognitive-test performance, patient-reported symptom probes and interviewer observations. Higher totals indicate a greater burden of delirium-related findings. The method does not require a second patient interview, and the authors did not propose a diagnostic cutoff: it is a severity measure, not an independent test of whether delirium is present.

Vasunilashorn and colleagues applied the method to the original 3D-CAM validation cohort of 201 older hospitalised adults, whose mean age was 84 years and of whom 28% had dementia. The raw score discriminated delirium determined by an independent clinical reference interview with an area under the curve of 0.950 and offered a substantially wider distribution than the earlier 0-7 3D-CAM-S method. This wider range may be useful for research, tracking change and representing subsyndromal symptoms.

The evidence remains internal because the analysis reused the parent instrument's original cohort. Responsiveness over time and relationships with length of stay, readmission and mortality were not tested. This page should link to the publication and authorised current 3D-CAM manual, while avoiding reproduction of the protected questions, prompts or feature-level operating rules.

Evidence and practical details

not applicable
Sensitivity*
not applicable
Specificity*
n=201
Sample
Full name
Raw 3D-CAM Delirium Severity Score
Catalogue class
Version or adaptation
Record type
core-version
Family
3d-cam-family
Related profiles
3D-CAM, 3D-CAM-S
Purpose
Severity measurement, Monitoring / repeated screening, Detailed research assessment
Population
Adult
Setting
General / acute hospital
Items
20
Administration
derived from the approximately 3-minute parent 3D-CAM; no separate interview
Evidence
No eligible DTA study identified
Evidence maturity
derivation-and-internal-validation
Evidence stage
development-or-derivation-only
DTA studies identified
0
Reference type
Secondary development and internal validation in the original 3D-CAM validation cohort
Reference standard
Independent clinical delirium reference interview used in the parent validation study
Validation sample
n = 201
Cut-off / scoring
0-20 severity range; no diagnostic threshold
Original/source citation
Vasunilashorn SM, Fick DM, Marcantonio ER, Schmitt EM, Inouye SK, Jones RN A new severity score for the 3-minute diagnostic interview for CAM-defined delirium Journal of the American Geriatrics Society. 2020;68(8):1874-1876. PMID 32479640

Format and clearly labelled links

One point is added for each positive result among the 20 core results already collected during 3D-CAM. These comprise seven cognitive-test results, three patient symptom reports and ten interviewer observations. The protected prompts and operating rules are not reproduced here.

Rights, version and permission record

Instrument access state
Rights-holder access page — permission required
Instrument host
American Delirium Society / Aging Brain Center instrument page
Current instrument/version note
Raw 0-20 3D-CAM severity method reported in 2020; use with the current authorised 3D-CAM version
Rights holder
Hospital Elder Life Program (copyright); Aging Brain Center (permissions administrator)
Licence / rights basis
ALL-RIGHTS-RESERVED-PERMISSION-REQUIRED
Rights checked
2026-07-19

Permission scope recorded at the last check

  • Clinical use: Use only under the current instrument instructions and any permission granted by the rights holder.
  • Research use: Permission status must be confirmed with the Aging Brain Center / rights holder.
  • Web republication: Not permitted without permission; link to the official page instead.
  • Translation/adaptation: Written permission required unless the exact instrument version carries a separate applicable licence.
  • EHR/software integration: Not verified; request permission.
  • Commercial use: Not verified; request permission.

Site-text licence boundary: the CC BY 4.0 notice for original deliriumtools.com editorial text does not cover third-party instruments, item wording, forms, article text, logos, screenshots or linked material.

Page record and review status

Page version
3.1.0
Last factual/source check
2026-07-19
Last rights/link check
2026-07-19
Curator and responsible editor
Professor Alasdair M J MacLullich — Curator factual and source review complete (not an independent external reviewer)
Independent external clinical review
Not yet completed. No independent external reviewer, consortium endorsement or institutional endorsement is claimed.

Corrections and rights-holder notices can be submitted through the contribute and corrections page.

* Where shown, sensitivity/specificity are from the cited evaluation and are not pooled estimates. “DTA studies identified” describes the current audit, not a completed systematic-review count. Citation metadata checked against PubMed or a publisher record does not imply validation, study quality, endorsement or suitability for a setting. See Methodology.